Glucagon-secretion inhibition using somatostatin: An old hormone for the treatment of diabetes-associated pancreatectomy

Diabetes Metab. 2017 Jun;43(3):269-271. doi: 10.1016/j.diabet.2016.08.002. Epub 2016 Sep 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Aged
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Female
  • Glucagon / blood*
  • Humans
  • Male
  • Middle Aged
  • Pancreatectomy / adverse effects*
  • Somatostatin / therapeutic use*

Substances

  • Somatostatin
  • Glucagon